Skip to main content

Preparation and Recellularization of Tissue Engineered Bioscaffold for Heart Valve Replacement

  • Chapter
Cardiovascular Regeneration Therapies Using Tissue Engineering Approaches

Summary

Tissue engineered grafts based on polymeric or acellular xenogeneric matrices have been widely studied, and found to have greater durability and functionality with growth potential and less immunogenicity than current bioprostheses. On the other hand, there are still several problems to be solved such as degradation control of biodegradable polymeric scaffolds and unwanted transfer of unknown animal related infectious diseases. In this chapter, our novel tissue processing of decellularization named PowerGraft by ultrahigh pressure treatment for safe tissue transplantation is reported. Porcine heart valves were isolated under sterile conditions and treated by cold isostatic pressing (CIP) at 4°C for disruption of donor cells. The cell debris was then washed out in PBS under microwave irradiation at 4°C. The tissues were completely cell free when they were treated by a CIP of 980 MPa (10,000 atm) for 10 min. There was no porcine endogeneous retrovirus (PERV) detected in the treated tissue. There were no significant changes in biomechanical properties of breaking strength and elastic modulus. From the in vitro incubation test, the tissues were disinfected when CIP was applied to the tissues contaminated by normal bacteria floras. The endothelial cells were well seeded on the acellular bioscaffold by the roller and circulation culture systems sequentially. This PowerGraft processing may provide a more durable and safe bioscaffold for tissue transplantation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bader A, Schilling T, Teebken OE, Brandes G, Herden T, Steinhoff G, Haverich A (1998) Tissue engineering of heart valves—human endothelial cell seeding of detergent acellularized porcine valves. Eur J Cardiothorac Surg 14(3):279–84

    Article  PubMed  CAS  Google Scholar 

  • Booth C, Korossis SA, Wilcox HE, Watterson KG, Kearney JN, Fisher J, Ingham E (2002) Tissue engineering of cardiac valve prostheses I: development and histological characterization of an acellular porcine scaffold. Heart Valve Dis 11(4):457–62

    Google Scholar 

  • Dohmen PM, Lembcke A, Hotz H, Kivelitz D, Konertz WF (2002) Ross operation with a tissue-engineered heart valve. Ann Thorac Surg 74(5): 1438–42

    Article  PubMed  Google Scholar 

  • Elkins RC, Goldstein S, Hewitt CW, Walsh SP, Dawson PE, Ollerenshaw JD, Black KS, Clarke DR, O’brien MF (2001) Recellularization of heart valve grafts by a process of adaptive remodeling. Semin Thorac Cardiovasc Surg 13(4 Suppl 1):87–92

    PubMed  CAS  Google Scholar 

  • Hayashi R (2002) High pressure in bioscience and biotechnology: pure science encompassed in pursuit of value. Biochim Biophys Acta 1595(1–2):397–9

    PubMed  CAS  Google Scholar 

  • Hildebrand DK, Wu ZJ, Mayer JE Jr, Sacks MS (2004) Design and hydrodynamic evaluation of a novel pulsatile bioreactor for biologically active heart valves. Ann Biomed Eng 32(8): 1039–49

    Article  PubMed  Google Scholar 

  • Laube HR, Matthaus M (2001) A new semi-automatic endothelial cell seeding technique for biological prosthetic heart valves. Int J Artif Organs 24(4):243–6

    PubMed  CAS  Google Scholar 

  • Magre S, Takeuchi Y, Bartosch B (2003) Xenotransplantation and pig endogenous retroviruses. Rev Med Virol 13(5):311–29

    Article  PubMed  Google Scholar 

  • Schenke-Layland K, Opitz F, Gross M, Doring C, Halbhuber KJ, Schirrmeister F, Wahlers T, Stock UA (2003) Complete dynamic repopulation of decellularized heart valves by application of defined physical signals-an in vitro study. Cardiovasc Res 60(3):497–509

    Article  PubMed  CAS  Google Scholar 

  • Simon P, Kasimir MT, Seebacher G, Weigel G, Ullrich R, Salzer-Muhar U, Rieder E, Wolner E (2003) Early failure of the tissue engineered porcine heart valve SYNERGRAFT™ in pediatric patients. Euro J Cardiothorac Surg 23:1002–6

    Article  CAS  Google Scholar 

  • Teebken OE, Puschmann C, Aper T, Haverich A, Mertsching H (2003) Tissue-engineered bioprosthetic venous valve: a long-term study in sheep. Eur J Vasc Endovasc Surg 25(4):305–12

    Article  PubMed  CAS  Google Scholar 

  • Zeltinger J, Landeen LK, Alexander HG, Kidd ID, Sibanda B (2001) Development and characterization of tissue-engineered aortic valves. Tissue Eng 7(1):9–22

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Tokyo

About this chapter

Cite this chapter

Fujisato, T. et al. (2005). Preparation and Recellularization of Tissue Engineered Bioscaffold for Heart Valve Replacement. In: Mori, H., Matsuda, H. (eds) Cardiovascular Regeneration Therapies Using Tissue Engineering Approaches. Springer, Tokyo. https://doi.org/10.1007/4-431-27378-6_7

Download citation

  • DOI: https://doi.org/10.1007/4-431-27378-6_7

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-23925-3

  • Online ISBN: 978-4-431-27378-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics